EUVIMED · CrossrefZeitschrift
Journal of the CardioMetabolic Syndrome
ISSN 1559-4564 · Wiley
Neueste Artikel
The Role of Adiponectin in Obesity, Diabetes, and Cardiovascular Disease
Statin Pleiotropy Against Renal Injury
Attenuation of Endocrine‐Exocrine Pancreatic Communication in Type 2 Diabetes: Pancreatic Extracellular Matrix Ultrastructural Abnormalities
Interrelationships Between Inflammation, C‐Reactive Protein, and Insulin Resistance
The Impact of Cardiovascular Risk Factor Case Management on the Metabolic Syndrome in a Primary Prevention Population: Results From a Randomized Controlled Trial
A Triglyceride/High‐Density Lipoprotein Ratio ≥3.5 Is Associated With an Increased Burden of Coronary Artery Disease on Cardiac Catheterization
C‐Reactive Protein and the Metabolic Syndrome: Useful Addition to the Cardiovascular Risk Profile?
The Role of Renin—Angiotensin System Blockade in the Management of Hypertension Associated With the Cardiometabolic Syndrome
The Cardiometabolic Syndrome and Cardiovascular Disease
Introduction: Organ Involvement in the Cardiometabolic Syndrome
Skeletal Muscle Insulin Resistance Is Fundamental to the Cardiometabolic Syndrome
Bone Metabolism and the Cardiometabolic Syndrome: Pathophysiologic Insights
The Role of β‐Cell Dysfunction in the Cardiometabolic Syndrome
Calciphylaxis and the Cardiometabolic Syndrome
Cardiometabolic Syndrome and Chronic Kidney Disease: What Is the Link?
Evaluation of Diastole in an Obese Young Woman: Mitral Valve Inflow Doppler vs. Mitral Annular Tissue Doppler Imaging
Hypertension and the Cardiometabolic Syndrome—Is It the Blood Pressure Lowering or the Blood Pressure Medication That Is Important?
The Journal of the CardioMetabolic Syndrome : Why It Is Needed
Nonalcoholic Steatohepatitis and the Cardiometabolic Syndrome
The Metabolic Syndrome: Prevalence and Associated Lifestyles in Japanese Workingmen
The Metabolic Syndrome Revisited: “Cardiometabolic Risk” Emerges as Common Ground Between Differing Views of the ADA and AHA
The Metabolic Syndrome: There's Little That's New Under the Sun!
Involvement of the Pancreatic Renin‐Angiotensin System in Insulin Resistance and the Metabolic Syndrome
Management of Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus as a Component of the Cardiometabolic Syndrome
Measurements of the Cyclic Variation of Myocardial Backscatter From Two‐Dimensional Echocardiographic Images as an Approach for Characterizing Diabetic Cardiomyopathy
Atherosclerotic Coronary Plaque in a Patient With the Metabolic Syndrome: Assessment by Lesion Physiology and Intravascular Ultrasound Virtual Histology
Abnormal Cardiac High‐Energy Phosphate Metabolism in a Patient With Type 2 Diabetes Mellitus
Perivascular Fat: Innocent Bystander or Active Player in Vascular Disease?
Prevalence of Hypertension in Type 2 Diabetes Mellitus: Impact of the Tightening Definition of High Blood Pressure and Association With Confounding Risk Factors
Prehypertension and the Cardiometabolic Syndrome: Is There Any Value in Pharmacologic Intervention?
EUVIMED